Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Dec 20, 2023 12:32pm
RE:RE:RE:New Press Release - Kane Biotech Receives Offer for its Interest in STEM Animal Health
The deposit is considerable and I would think no more than perhaps 5-10% of the agreed price. Regardless, the funds will be a significant bridge into the next phase.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Dec 20, 2023 10:38am
RE:RE:New Press Release - Kane Biotech Receives Offer for its Interest in STEM Animal Health
Good comment/info LSCFA. That was a few years ago when they didn't have VOHC certifications and not much sales. I hope the deal will be for 8.5MM+. This would allow them to pay their credit line
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2136)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Dec 20, 2023 10:25am
RE:New Press Release - Kane Biotech Receives Offer for its Interest in STEM Animal Health
Animalcare invested $3M for a 1/3 stake in STEM valuing it at $10M, so Kane's 2/3 stake is worth at least $6.6M.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Dec 20, 2023 10:18am
RE:New Press Release - Kane Biotech Receives Offer for its Interest in STEM Animal Health
Nice update this morning. First, there is an offer on the table for the sale of the STEM division. Secondly, the offer seems good enough for Pivot Financials to extend the credit facility until the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 20, 2023 8:29am
New Press Release - Kane Biotech Receives Offer for its Interest in STEM Animal Health
Proposed transaction allows for sharpened focus on Human Health WINNIPEG, Manitoba, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on December 19, 2023, it signed a non-binding offer for the sale of its...
read article.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Dec 15, 2023 1:29pm
RE:RE:So, what's next ?
Very quiet since the last financials. No news or communication regarding any of the points mentioned in my previous post. The only thing we know is that KNE is producing roughly 2000 oz of Revyve
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Dec 04, 2023 5:46pm
RE:So, what's next ?
Next 'things' to look for are; 1. Credit facility needs to be re-negotiated; 2. Update on the animal division sales/spin-off/etc...; 3. DispersinB trials Best scenario would be to sell
...more
(201)
•••
RoyMax123
X
View Profile
View Bullboard History
Post by
RoyMax123
on Dec 04, 2023 3:12pm
So, what's next ?
The maturity date of the amended credit facility have expired again and dead silence from the Co. This is getting beyond ridiculous...
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 28, 2023 4:05pm
New Press Release - Kane Biotech Announces Improved Third Quarter 2023 Financial Results
29% Increase in Product and Services Revenue; 26% Increase in Total Revenue WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third Quarter Financial...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 21, 2023 7:45am
New Press Release - Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 - Conference Call to Follow
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 16, 2023 1:46pm
New Press Release - Kane Biotech Strengthens Board with Biotech Executive
Accomplished executive with over two decades of senior biotechnology expertise joins Kane’s Board of Directors WINNIPEG, Manitoba, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) is pleased to announce that John Coleman has...
read article.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 11, 2023 3:41pm
RE:RE:RE:RE:RE:RE:RE:Progenacare is now listing revyve on their website
I don't know, tell us all how it is...
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 11, 2023 11:30am
RE:RE:RE:RE:RE:RE:Progenacare is now listing revyve on their website
What's it like to be wrong all the time?
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 09, 2023 2:06pm
RE:RE:RE:RE:RE:Progenacare is now listing revyve on their website
Thank you KevinOleary, the quality of your posts are well above average, thanks for sharing your opinions with the community. P.S. Don't forget to take your pills, you'll feel better.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >